Skip to main content
Figure 1 | Cost Effectiveness and Resource Allocation

Figure 1

From: Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability

Figure 1

Survival, by strategy, for a single cohort of treated individuals only (Upper Panel) and a single cohort of both treated and untreated individuals (Lower Panel) when treatment slots are limited to 50,000. On the x- axis is time; on the y- axis is the proportion alive. By 5 years, survival among a single cohort of treated individuals in the Status Quo exceeds survival among treated individuals in the Alternative strategy. In contrast, for a single cohort of treated and untreated individuals followed over 5 years, survival under the Alternative strategy exceeds survival under the Status Quo.

Back to article page